In last trading session, Oragenics Inc (AMEX:OGEN) saw 0.45 million shares changing hands with its beta currently measuring 0.85. Company’s recent per share price level of $0.29 trading at $0.01 or 1.03% at ring of the bell on the day assigns it a market valuation of $3.59M. That closing price of OGEN’s stock is at a discount of -1224.14% from its 52-week high price of $3.84 and is indicating a premium of 13.79% from its 52-week low price of $0.25.

Oragenics Inc (AMEX:OGEN) trade information

Upright in the green during last session for gaining 1.03%, in the last five days OGEN remained trading in the red while hitting it’s week-highest on Wednesday, 02/19/25 when the stock touched $0.29 price level, adding 4.95% to its value on the day. Oragenics Inc’s shares saw a change of -22.64% in year-to-date performance and have moved -2.82% in past 5-day. Oragenics Inc (AMEX:OGEN) showed a performance of 0.49% in past 30-days.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 29.34% during past 5 years.

On the other hand, Fidelity Extended Market Index Fund and Vanguard Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024 , the former fund manager was holding 29.56 shares of worth $8446.0 or 0.24% of the total outstanding shares. The later fund manager was in possession of 8.87 shares on Sep 30, 2024 , making its stake of worth around $2533.0 in the company or a holder of 0.07% of company’s stock.